Carlos Caldas

The Hebrew University of Jerusalem invites applications for a PhD position in cancer bioinformatics and computational biology, based at the Faculty of Medicine’s Ein Kerem campus. The Caldas Lab, part of the Lautenberg Center for Immunology and Cancer Research, offers a vibrant interdisciplinary environment with advanced infrastructure for cutting-edge biomedical research. The lab’s research focuses on the functional genomics of breast cancer, molecular taxonomy, and the development of novel biomarkers and therapeutics. It has pioneered studies in circulating tumor DNA (ctDNA) as a monitoring biomarker and liquid biopsy, and utilizes patient-derived tumor explants as in vivo cancer models. Building on foundations established at the University of Cambridge, the new Caldas laboratory pursues two integrated research directions: modeling cancer ecosystems in space and time using patient-derived tumor xenografts (PDTXs) and immune cells, and developing novel cancer biomarkers and therapeutics through multi-omics, dynamic disease monitoring, and data integration using machine learning and artificial intelligence. The PhD project will involve analysis of single cell and spatial profiling data, deploying machine learning and deep learning approaches to unravel the complexity of malignant tumors and their microenvironments. Professor Carlos Caldas, a highly cited researcher and award-winning scientist, leads the lab. He brings extensive experience from the University of Cambridge and is recognized for his contributions to cancer medicine and genomics. The Hebrew University is a global top 100 institution, renowned for its research excellence and diverse academic community. The campus is located in Jerusalem, a city rich in history and culture, offering students a unique blend of academic and social opportunities. Funding is available, with a monthly stipend of 2200-2600 USD. Applicants must hold an MSc in computer science, computational biology, or bioinformatics, with a strong academic record (BSc GPA 3.5+ and MSc with merit). Candidates should be motivated, collaborative, and possess excellent English skills. The university values diversity and inclusion, welcoming students from all backgrounds. To apply, submit three separate PDFs: a letter of motivation, CV (including publications), copies of academic degrees and transcripts, and names and contacts of at least two references. The application deadline is March 1st, 2026. For more information and to apply, visit the provided application link.

The Hebrew University of Jerusalem invites applications for a PhD position in Cancer Spatial Biology, based at the Faculty of Medicine’s Ein Kerem campus in Jerusalem. This internationally acclaimed research institution is renowned for its pioneering biomedical research and progressive health care, fostering an interdisciplinary environment that brings together researchers from across the globe. The successful candidate will join the Caldas Lab, part of the Lautenberg Center for Immunology and Cancer Research. The Center is dedicated to advancing basic immunology and cancer research, providing state-of-the-art infrastructure and a stimulating environment for scientists and students. The Caldas Lab has a distinguished history in functional genomics of breast cancer, having played a central role in redefining molecular taxonomy, establishing ctDNA as a biomarker, and pioneering patient-derived tumor explants as in vivo models. Recent work integrates multi-omics approaches with machine learning to predict therapy response, and the new lab at Hebrew University builds on foundations established at the University of Cambridge. Research directions include modeling cancer ecosystems in space and time using patient-derived tumor xenografts and immune cells, and developing novel cancer biomarkers and therapeutics through multi-omics, dynamic disease monitoring, and advanced data integration using machine learning and artificial intelligence. The PhD project focuses on developing advanced spatial biology methods, such as spatial transcriptomics and spatial proteomics, with particular emphasis on tracking clones in situ. Supervision will be provided by Professor Carlos Caldas, a highly cited researcher and award-winning leader in cancer medicine, recently appointed as Full Professor at Hebrew University. Professor Caldas brings extensive experience from the University of Cambridge and has received numerous international honors for his contributions to cancer research. Funding is available, with a monthly stipend ranging from 2200 to 2600 USD. Applicants must hold an MSc in cancer biology, with expertise in spatial biology considered an advantage. A strong academic record is required (BSc GPA 3.5+ and MSc with merit), along with scientific curiosity, motivation for collaborative and interdisciplinary research, and excellent English proficiency. Hebrew University is committed to diversity, equity, and inclusion, welcoming students from all backgrounds. To apply, submit three separate PDFs: a letter of motivation, CV (including publications), copies of academic degrees and transcripts, and names and contacts of at least two references. Applications should be submitted via the provided link by March 1st, 2026. The Hebrew University of Jerusalem is a global top 100 university, with a vibrant academic community and a rich cultural environment in the heart of Jerusalem. Students enjoy access to world-class research facilities, diverse cultural experiences, and a supportive, inclusive campus atmosphere.

The Hebrew University of Jerusalem invites applications for a Postdoctoral Fellow position in cancer bioinformatics and computational biology, based at the Faculty of Medicine’s Ein Kerem campus. The Caldas Lab, part of the Lautenberg Center for Immunology and Cancer Research, offers a vibrant interdisciplinary environment with advanced infrastructure for cutting-edge biomedical research. The lab’s research focuses on the functional genomics of breast cancer, molecular taxonomy, and the development of novel biomarkers and therapeutics. Recent work integrates multi-omics approaches and machine learning to predict therapy response and monitor disease progression. The successful candidate will analyze bulk, single-cell, and spatial multi-omics data, deploying machine learning and deep learning techniques. Research directions include modeling cancer ecosystems using patient-derived tumor xenografts and immune cells, and developing new cancer biomarkers through dynamic disease monitoring and data integration. The lab is led by Professor Carlos Caldas, a globally recognized expert in cancer medicine, with a distinguished record of scientific leadership and innovation. Applicants must have a PhD in computer science, computational biology, or bioinformatics, a strong publication record, motivation for collaborative and interdisciplinary research, and excellent English skills. The position offers a monthly stipend of 3450-4100 USD. Hebrew University is committed to diversity, equity, and inclusion, welcoming candidates from all backgrounds. The university is a global top 100 institution, renowned for its research excellence and international community. To apply, submit three separate PDFs: a letter of motivation, CV with publications, copies of academic degrees and transcripts, and names and contacts of at least two references. The application deadline is March 1st, 2026. For more information and to apply, visit the provided application link. Located in Jerusalem, the university offers a unique cultural and academic experience, with access to a diverse student body and a city rich in history and modern attractions.